This series of learning modules lays the groundwork for understanding acute hepatic porphyria, recognizing symptoms, and gaining insight into how it may affect your patients. Modules can be viewed online and/or downloaded as PDFs.
Pathophysiology of Acute Hepatic Porphyria (AHP)
Module 2 Reviews:
- Evidence for the role of ALA (aminolevulinic acid) and PBG (porphobilinogen) in attacks
- How attacks and, for some patients, chronic symptoms are associated with widespread neurologic lesions, leading to dysfunction across the autonomic, central, and peripheral nervous systems
AHP Diagnosis and
This helpful flyer summarizes:
- What AHP is
- The signs and symptoms
- Using random (spot) urine testing
- Consequences of delayed diagnosis
AHP Random Urine
This detailed guide includes:
- Testing and protocol information from major US laboratories
CREATING AHP RANDOM (SPOT) URINE TEST PANELS IN ELECTRONIC HEALTH RECORD (EHR) SYSTEMS
See instructions for creating AHP random (spot) urine test panels for some of the most common EHR systems.
gGASTRO AHP URINE TEST EHR INSTRUCTIONS
EPIC AHP URINE TEST EHR INSTRUCTIONS
eCLINICALWORKS AHP URINE TEST EHR
NEXTGEN AHP URINE TEST EHR INSTRUCTIONS
Access Additional Resources
For more information about AHP and other forms of porphyria, please visit American Porphyria Foundation, The Porphyrias Consortium, the National Organization for Rare Disorders, and Global Genes. These independent organizations are dedicated to helping healthcare providers, patients, and their caregivers understand porphyria. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on the sites that are not owned and operated by Alnylam.